1256778-02-5

Basic information

• Product Name: 2-fluoro-4-formyl-6-methoxyphenyl trifluoromethanesulfonate
• Synonyms: 2-fluoro-4-formyl-6-methoxyphenyl trifluoromethanesulfonate
• CAS NO: 1256778-02-5
• Molecular Weight: 302.203
• Mol File: 1256778-02-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-fluoro-4-formyl-6-methoxyphenyl trifluoromethanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluoro-4-formyl-6-methoxyphenyl trifluoromethanesulfonate(1256778-02-5)
• EPA Substance Registry System: 2-fluoro-4-formyl-6-methoxyphenyl trifluoromethanesulfonate(1256778-02-5)

Safety Data

• Hazardous Substances Data: 1256778-02-5(Hazardous Substances Data)

Upstream product

• 79418-78-3 3-fluoro-4-hydroxy-5-methoxybenzaldehyde 
• 1025373-45-8 trifluoromethanesulfonic acid anhydride 
• 358-23-6 trifluoromethylsulfonic anhydride 

Downstream Products

• 1256778-03-6 3-fluoro-5-methoxy-4-(2-methyl-propenyl)-benzaldehyde 

Relevant articles and documents

BTK INHIBITORS

The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, Formula I or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.

(DIHYDRO) IMIDAZOISO (5, 1-A) QUINOLINES AS FSH RECEPTOR AGONISTS FOR THE TREATMENT OF FERTILITY DISORDERS

The invention relates to imidazoiso[5,1-a]quinoline and 5,6-dihydro-imidazoiso[5,1-a]quinoline derivatives according to general Formula (1) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of infertility.